SCHEMBL25917430

SCHEMBL25917430

NC(=O)CNC(=O)CCCCC(=O)NCC(N)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.54
GAA P10253 1/20 0.47
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
FAAH O00519 8/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
PTPN1 P18031 1/20 0.40
MAPT P10636 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SLC6A5 Q9Y345 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
TPSAB1 Q15661 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15185922 0.89 MAOA (0.53) RECQLGAAFAAHHDAC3HDAC1
SCHEMBL23587955 0.89 RECQL (0.50) RECQLGAATSHRSMN1; SMN2FAAH
SCHEMBL7345186 0.89 FAAH (0.61) RECQLGAAFAAHMAPTALDH1A1
SCHEMBL15764778 0.88 MAOA (0.47) RECQLGAATSHRSMN1; SMN2FAAH
SCHEMBL29060568 0.87 FAAH (0.64) GAAFAAHMEN1KMT2ASLC6A5
SCHEMBL15840422 0.87 MAOA (0.47) RECQLGAATSHRSMN1; SMN2FAAH
SCHEMBL9664722 0.87 FAAH (0.64) GAAFAAHMEN1KMT2ASLC6A5
SCHEMBL9664810 0.87 FAAH (0.64) GAAFAAHMEN1KMT2ASLC6A5
SCHEMBL7520244 0.87 FAAH (0.64) GAAFAAHMEN1KMT2ASLC6A5
SCHEMBL9664822 0.87 FAAH (0.64) GAAFAAHMEN1KMT2ASLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220737-A2 OLIGONUCLEOTIDES HAVING A SYNTHETIC BACKBONE AND SYNTHESIS THEREOF ADARX PHARMACEUTICALS, INC. (US) 2023-11-16 WO disclosed
EP-4219718-A2 COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2023-08-02 EP disclosed